President and CEO
BioCanRx

Dr. Stéphanie Michaud is the President and CEO of BioCanRx, a not-for-profit that seeks to accelerate the delivery of innovative immunotherapies from the bench to the bedside. In this position, she is responsible for running all facets of the organization. She brings more than 20 years of public, government and private sector experience in research and Science & Technology innovation policy. She strives to create partnerships between government, not-for-profits, academia and industry to maximize the impact of research funded by the BioCanRx network on the lives of those affected by cancer. Prior to joining BioCanRx, Dr. Michaud was Deputy Director of the flagship Government of Canada Networks Centres of Excellence (NCE) program. In addition to responsibility for its performance, management and delivery, she led the implementation of high profile bilateral international initiatives and provided strategic advice to government and stakeholders. She is a strong contributor to S&T policy, most notably in intellectual property. Dr. Michaud earned a PhD in Organic Chemistry from McGill University. She is involved with a number of not-for-profit organizations and is a member of the Board of Directors of the Stem Cell Network.